Centessa Pharmaceuticals | 10-K: Annual report
Centessa Pharmaceuticals | 8-K: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Centessa Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Anderson Karen M.
Centessa Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Centessa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(5.8%),Oleg Nodelman(5.8%), etc.
Centessa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.0%),BVF Inc.(9.0%), etc.
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Weinhoff Gregory M
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer HUSSAIN IQBAL J
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer CHAO DAVID M
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer SAHA SAURABH
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Anderson Karen M.
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bush Tia L
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rotman Harris
Centessa Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Centessa Pharmaceuticals | 8-K: Current report
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer CHAO DAVID M
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Weinhoff Gregory M
Centessa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer HUSSAIN IQBAL J
No Data